Tutewohl Steve
SEC CIK 1811845 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EVH | Evolent Health, Inc. | COO | 136.3K | — | $1.95M | 24 | 2021-07-01 | 2023-07-01 |
Most active insiders at EVH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McCarthy Daniel Joseph | Pres | — | $329.5K |
| 2 | Springstubb Brendan B | Dir | $38.2K | — |
| 3 | Glass Russell Monroe | Dir | — | — |
| 4 | Ajayi Toyin | Dir | — | — |
| 5 | Ramos Mario | CFO | — | — |
| 6 | KECK KIM | Dir | — | — |
| 7 | Shams Aammaad | CAO | — | — |
| 8 | Jelinek Richard M | Dir | — | — |
| 9 | Blackley Seth | CEO, Dir | — | — |
| 10 | Weinberg Jonathan | GC | — | — |
Tutewohl Steve made no open-market trades at EVH in the last 12 months.
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-26 | 2023-07-01 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | A - Grant | $0.00 | +9,000 | 136.3K | +7% | $0 | |
| M | 2023-03-03 | 2023-03-01+ | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | F - Tax | $35.19 | -5,376 | 127.3K | -4% | -$189.2K |
| 2023-03-03 | 2023-03-01 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | A - Grant | $0.00 | +17.0K | 132.7K | +15% | $0 | |
| 2023-02-23 | 2023-02-21 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | A - Grant | $0.00 | +14.3K | 120.5K | +13% | $0 | |
| 2023-02-23 | 2023-02-21 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | F - Tax | $28.08 | -4,774 | 115.7K | -4% | -$134.1K | |
| 2022-07-05 | 2022-07-01 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | F - Tax | $31.12 | -2,251 | 106.2K | -2% | -$70.1K | |
| 2022-03-07 | 2022-03-03 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | S - Sale | $27.30 | -1,918 | 108.4K | -2% | -$52.4K | |
| 2022-03-04 | 2022-03-02 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | F - Tax | $27.54 | -4,499 | 110.3K | -4% | -$123.9K | |
| D | 2022-03-03 | 2022-03-01 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | A - Grant | $0.00 | +20.0K | 118.8K | +20% | $0 |
| D | 2022-03-03 | 2022-03-01 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | S - Sale+OE | $27.41 | -5,388 | 114.8K | -4% | -$147.7K |
| D | 2022-03-03 | 2022-03-01 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | M - OptEx | $13.29 | +5,388 | 121.1K | +5% | +$71.6K |
| D | 2022-03-03 | 2022-03-01 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | F - Tax | $27.40 | -4,005 | 114.8K | -3% | -$109.7K |
| 2022-02-07 | 2022-02-03 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | S - Sale | $22.85 | -1,707 | 98.8K | -2% | -$39.0K | |
| D | 2022-02-01 | 2022-02-01 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | S - Sale+OE | $23.47 | -6,313 | 100.5K | -6% | -$148.2K |
| D | 2022-02-01 | 2022-02-01 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | M - OptEx | $13.95 | +6,313 | 106.9K | +6% | +$88.1K |
| 2021-09-02 | 2021-09-01 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | S - Sale | $25.05 | -13.6K | 100.5K | -12% | -$339.5K | |
| DM | 2021-08-04 | 2021-08-02+ | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | S - Sale+OE | $23.02 | -31.0K | 114.1K | -21% | -$713.3K |
| DM | 2021-08-04 | 2021-08-02+ | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | M - OptEx | $15.87 | +31.0K | 117.4K | +36% | +$491.8K |
| DM | 2021-07-13 | 2021-07-09 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | S - Sale+OE | $22.63 | -13.8K | 114.1K | -11% | -$313.5K |
| DM | 2021-07-13 | 2021-07-09 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | M - OptEx | $13.90 | +13.8K | 115.9K | +14% | +$192.5K |
| D | 2021-07-12 | 2021-07-08 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | S - Sale+OE | $22.00 | -200 | 114.1K | -0.2% | -$4,400 |
| D | 2021-07-12 | 2021-07-08 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | M - OptEx | $13.29 | +200 | 114.3K | +0.2% | +$2,658 |
| D | 2021-07-02 | 2021-07-01 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | M - OptEx | $7.83 | +9,352 | 123.5K | +8% | +$73.2K |
| D | 2021-07-02 | 2021-07-01 | EVH | Evolent Health, Inc. | Tutewohl Steve | COO | S - Sale+OE | $21.05 | -9,352 | 114.1K | -8% | -$196.9K |
Purchase Sale Sale after option exercise All abbreviations